Our news

InspectT receives convertible loan from Innovatiefonds Noord-Holland

October 7, 2025
In the mediaNew venture

InspectT receives funding from Innovatiefonds Noord-Holland for the development of an Optical-DOSY flow cell. The funding supports the research and development of a dedicated flow cell for Optical-DOSY, a new spectroscopy method that turns standard optical spectrometers into instruments capable of measuring both molecular structure and size.

Optical Diffusion-Ordered Spectroscopy (Optical-DOSY) combines optical spectroscopy with diffusion-coefficient analysis. The measurement is non-destructive, requires minimal sample preparation, and can be performed by simply inserting the flow cell into a standard optical spectrometer.

Applications areas include (bio)pharma, life sciences, and materials research, where fast and reliable size- and structure-characterization of proteins, polymers, and small molecules shortens development cycles and reduces costs.

Giulia Giubertoni, co-founder and CEO of InspectT:
“With Optical-DOSY, we add size sensitivity to the optical spectrometers that most labs already have in-house. By developing a dedicated flow cell, we will ensure easy integration and reproducible results—making molecular size analysis faster and more accessible.”

Prof. Sander Woutersen, University of Amsterdam:
“Optical-DOSY opens new possibilities to characterize complex samples, from proteins to polymers to nanoparticles. And the nice thing is that it works with any kind of spectrometer: UV/Vis, infrared, Raman, whatever is most suitable for the sample that you want to investigate.”

About InspectT
InspectT was founded by [founder name(s)]. The company is developing Optical-DOSY, a patented method that makes spectrometers size-sensitive for fast, reliable characterization of molecules in complex samples.

Our latest news

Read other articles

October 13, 2025
In the mediaInvestmentNew venture

‘Invest International’ invests in Plantics to accelerate international scale up

September 26, 2025
In the mediaNew venture

AviSia Therapeutics receives convertible loan from Innovatiefonds Noord-Holland

September 8, 2025
In the mediaNew venture

First babies in the Netherlands protected against RSV by Amsterdam UMC invention

Is there something you think we should share? Leave us a message.